Expert Interview
Looking at Roche's cobas® liat molecular test for point-of-care screening of sexually transmitted infections
Ticker(s): RHHBYInstitution: One Urology
- Urologist at One Urology in California.
- Currently manages 125-200 patients with bladder cancer.
- Clinical focus on urologic cancer, stone disease, incontinence, erectile dysfunction, men’s health, and infertility.
Describe your background and current practice setting
Added By: ben_adminWhat is your opinion on the potential of the cobas liat molecular test?
What is the current gold standard for the diagnosis of an STI?
Added By: ben_adminRank your excitement for cobas liat molecular test on a scale of 1-10?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
